Cargando…
COVID-19 and emerging viral infections: The case for interferon lambda
With the first reports on coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the scientific community working in the field of type III IFNs (IFN-λ) realized that this class of IFNs could play an important role in this and o...
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Rockefeller University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155807/ https://www.ncbi.nlm.nih.gov/pubmed/32289152 http://dx.doi.org/10.1084/jem.20200653 |
| _version_ | 1783522112439320576 |
|---|---|
| author | Prokunina-Olsson, Ludmila Alphonse, Noémie Dickenson, Ruth E. Durbin, Joan E. Glenn, Jeffrey S. Hartmann, Rune Kotenko, Sergei V. Lazear, Helen M. O’Brien, Thomas R. Odendall, Charlotte Onabajo, Olusegun O. Piontkivska, Helen Santer, Deanna M. Reich, Nancy C. Wack, Andreas Zanoni, Ivan |
| author_facet | Prokunina-Olsson, Ludmila Alphonse, Noémie Dickenson, Ruth E. Durbin, Joan E. Glenn, Jeffrey S. Hartmann, Rune Kotenko, Sergei V. Lazear, Helen M. O’Brien, Thomas R. Odendall, Charlotte Onabajo, Olusegun O. Piontkivska, Helen Santer, Deanna M. Reich, Nancy C. Wack, Andreas Zanoni, Ivan |
| author_sort | Prokunina-Olsson, Ludmila |
| collection | PubMed |
| description | With the first reports on coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the scientific community working in the field of type III IFNs (IFN-λ) realized that this class of IFNs could play an important role in this and other emerging viral infections. In this Viewpoint, we present our opinion on the benefits and potential limitations of using IFN-λ to prevent, limit, and treat these dangerous viral infections. |
| format | Online Article Text |
| id | pubmed-7155807 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Rockefeller University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71558072020-04-19 COVID-19 and emerging viral infections: The case for interferon lambda Prokunina-Olsson, Ludmila Alphonse, Noémie Dickenson, Ruth E. Durbin, Joan E. Glenn, Jeffrey S. Hartmann, Rune Kotenko, Sergei V. Lazear, Helen M. O’Brien, Thomas R. Odendall, Charlotte Onabajo, Olusegun O. Piontkivska, Helen Santer, Deanna M. Reich, Nancy C. Wack, Andreas Zanoni, Ivan J Exp Med Viewpoint With the first reports on coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the scientific community working in the field of type III IFNs (IFN-λ) realized that this class of IFNs could play an important role in this and other emerging viral infections. In this Viewpoint, we present our opinion on the benefits and potential limitations of using IFN-λ to prevent, limit, and treat these dangerous viral infections. Rockefeller University Press 2020-04-14 /pmc/articles/PMC7155807/ /pubmed/32289152 http://dx.doi.org/10.1084/jem.20200653 Text en © 2020 Prokunina-Olsson et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
| spellingShingle | Viewpoint Prokunina-Olsson, Ludmila Alphonse, Noémie Dickenson, Ruth E. Durbin, Joan E. Glenn, Jeffrey S. Hartmann, Rune Kotenko, Sergei V. Lazear, Helen M. O’Brien, Thomas R. Odendall, Charlotte Onabajo, Olusegun O. Piontkivska, Helen Santer, Deanna M. Reich, Nancy C. Wack, Andreas Zanoni, Ivan COVID-19 and emerging viral infections: The case for interferon lambda |
| title | COVID-19 and emerging viral infections: The case for interferon lambda |
| title_full | COVID-19 and emerging viral infections: The case for interferon lambda |
| title_fullStr | COVID-19 and emerging viral infections: The case for interferon lambda |
| title_full_unstemmed | COVID-19 and emerging viral infections: The case for interferon lambda |
| title_short | COVID-19 and emerging viral infections: The case for interferon lambda |
| title_sort | covid-19 and emerging viral infections: the case for interferon lambda |
| topic | Viewpoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155807/ https://www.ncbi.nlm.nih.gov/pubmed/32289152 http://dx.doi.org/10.1084/jem.20200653 |
| work_keys_str_mv | AT prokuninaolssonludmila covid19andemergingviralinfectionsthecaseforinterferonlambda AT alphonsenoemie covid19andemergingviralinfectionsthecaseforinterferonlambda AT dickensonruthe covid19andemergingviralinfectionsthecaseforinterferonlambda AT durbinjoane covid19andemergingviralinfectionsthecaseforinterferonlambda AT glennjeffreys covid19andemergingviralinfectionsthecaseforinterferonlambda AT hartmannrune covid19andemergingviralinfectionsthecaseforinterferonlambda AT kotenkosergeiv covid19andemergingviralinfectionsthecaseforinterferonlambda AT lazearhelenm covid19andemergingviralinfectionsthecaseforinterferonlambda AT obrienthomasr covid19andemergingviralinfectionsthecaseforinterferonlambda AT odendallcharlotte covid19andemergingviralinfectionsthecaseforinterferonlambda AT onabajooluseguno covid19andemergingviralinfectionsthecaseforinterferonlambda AT piontkivskahelen covid19andemergingviralinfectionsthecaseforinterferonlambda AT santerdeannam covid19andemergingviralinfectionsthecaseforinterferonlambda AT reichnancyc covid19andemergingviralinfectionsthecaseforinterferonlambda AT wackandreas covid19andemergingviralinfectionsthecaseforinterferonlambda AT zanoniivan covid19andemergingviralinfectionsthecaseforinterferonlambda |